Immunization of mice with plasmid DNA expressing the measles virus nucleoprotein gene

The measles virus (MV) nucleocapsid (N) protein gene has been inserted into a plasmid vector so as to place the gene under the control of the strong constitutive human cytomegalovirus major immediate early promoter. On intramuscular injection of pMV64 DNA into C3H/He mice, seroconversion with increa...

Full description

Saved in:
Bibliographic Details
Published in:Viral immunology Vol. 9; no. 2; p. 65
Main Authors: Fooks, A R, Jeevarajah, D, Warnes, A, Wilkinson, G W, Clegg, J C
Format: Journal Article
Language:English
Published: United States 01.01.1996
Subjects:
Animals
Antibodies, Viral - blood
Cell Line
DNA, Viral - immunology
Gene Expression
Humans
Immunization
Immunoglobulin G - blood
Measles - prevention & control
Measles Vaccine
Measles virus - genetics
Mice
Mice, Inbred C3H
Nucleoproteins - genetics
Plasmids - genetics
Vaccines, DNA
Viral Proteins - genetics
ISSN:0882-8245
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract The measles virus (MV) nucleocapsid (N) protein gene has been inserted into a plasmid vector so as to place the gene under the control of the strong constitutive human cytomegalovirus major immediate early promoter. On intramuscular injection of pMV64 DNA into C3H/He mice, seroconversion with increasing titers of N-specific serum IgG antibodies was observed over a period of 3 months. However, when 3-week-old mice were immunized by intramuscular injection of pMV64 in a two-dose schedule, and challenged intracranially with a rodent-adapted measles virus strain (CAM/RB) at 5 weeks of age, no significant protective response was seen. The lack of effective protection evoked by DNA immunization in this model, where MV challenge must take place before 8 weeks of age, may be due to inefficient induction of cell-mediated immunity resulting from expression in muscle tissue, compounded by a relatively slow rise in immune response compared with that seen with the recombinant adenovirus.
AbstractList The measles virus (MV) nucleocapsid (N) protein gene has been inserted into a plasmid vector so as to place the gene under the control of the strong constitutive human cytomegalovirus major immediate early promoter. On intramuscular injection of pMV64 DNA into C3H/He mice, seroconversion with increasing titers of N-specific serum IgG antibodies was observed over a period of 3 months. However, when 3-week-old mice were immunized by intramuscular injection of pMV64 in a two-dose schedule, and challenged intracranially with a rodent-adapted measles virus strain (CAM/RB) at 5 weeks of age, no significant protective response was seen. The lack of effective protection evoked by DNA immunization in this model, where MV challenge must take place before 8 weeks of age, may be due to inefficient induction of cell-mediated immunity resulting from expression in muscle tissue, compounded by a relatively slow rise in immune response compared with that seen with the recombinant adenovirus.The measles virus (MV) nucleocapsid (N) protein gene has been inserted into a plasmid vector so as to place the gene under the control of the strong constitutive human cytomegalovirus major immediate early promoter. On intramuscular injection of pMV64 DNA into C3H/He mice, seroconversion with increasing titers of N-specific serum IgG antibodies was observed over a period of 3 months. However, when 3-week-old mice were immunized by intramuscular injection of pMV64 in a two-dose schedule, and challenged intracranially with a rodent-adapted measles virus strain (CAM/RB) at 5 weeks of age, no significant protective response was seen. The lack of effective protection evoked by DNA immunization in this model, where MV challenge must take place before 8 weeks of age, may be due to inefficient induction of cell-mediated immunity resulting from expression in muscle tissue, compounded by a relatively slow rise in immune response compared with that seen with the recombinant adenovirus.
The measles virus (MV) nucleocapsid (N) protein gene has been inserted into a plasmid vector so as to place the gene under the control of the strong constitutive human cytomegalovirus major immediate early promoter. On intramuscular injection of pMV64 DNA into C3H/He mice, seroconversion with increasing titers of N-specific serum IgG antibodies was observed over a period of 3 months. However, when 3-week-old mice were immunized by intramuscular injection of pMV64 in a two-dose schedule, and challenged intracranially with a rodent-adapted measles virus strain (CAM/RB) at 5 weeks of age, no significant protective response was seen. The lack of effective protection evoked by DNA immunization in this model, where MV challenge must take place before 8 weeks of age, may be due to inefficient induction of cell-mediated immunity resulting from expression in muscle tissue, compounded by a relatively slow rise in immune response compared with that seen with the recombinant adenovirus.
Author Jeevarajah, D
Warnes, A
Clegg, J C
Fooks, A R
Wilkinson, G W
Author_xml – sequence: 1
  givenname: A R
  surname: Fooks
  fullname: Fooks, A R
  organization: Centre for Applied Microbiology and Research, Salisbury, U.K
– sequence: 2
  givenname: D
  surname: Jeevarajah
  fullname: Jeevarajah, D
– sequence: 3
  givenname: A
  surname: Warnes
  fullname: Warnes, A
– sequence: 4
  givenname: G W
  surname: Wilkinson
  fullname: Wilkinson, G W
– sequence: 5
  givenname: J C
  surname: Clegg
  fullname: Clegg, J C
BackLink https://www.ncbi.nlm.nih.gov/pubmed/8822623$$D View this record in MEDLINE/PubMed
BookMark eNotkDtrwzAUhTWkpEnasWNBUze7lmTZ8hjSVyC0SzOba-k6UbFk17LTx6-voZkOHD6-A2dJZr71SMgNS2KWqOL-ZF3MiiKLiziTM7JIlOKR4qm8JMsQPpIkUZkSczKfep5xsSD7rXOjt78w2NbTtqbOaqRfdjjSroHgrKEPr2uK312PIVh_oMMRqUMIDQZ6sv0YqB91g23XtwNaTw_o8Ypc1NAEvD7niuyfHt83L9Hu7Xm7We8iLQo1RJlQwLkpRJVKqEzKai1AauC1SSsNDIGlwGVeCYkV16zOlck10wA6NUwaviJ3_95p_HPEMJTOBo1NAx7bMZS5EpnkPJ3A2zM4Vg5N2fXWQf9Tnn_gf1yLYVw
CitedBy_id crossref_primary_10_1038_77506
crossref_primary_10_1586_14760584_7_8_1215
crossref_primary_10_1016_S0264_410X_00_00454_0
crossref_primary_10_1007_BF00870273
crossref_primary_10_1016_S0264_410X_02_00048_8
crossref_primary_10_1016_j_jviromet_2013_11_015
crossref_primary_10_1016_S0020_7519_03_00062_6
crossref_primary_10_1016_S0165_2478_03_00132_9
crossref_primary_10_1586_erv_11_198
crossref_primary_10_1006_viro_1999_9666
crossref_primary_10_1089_vim_2020_0082
crossref_primary_10_1006_viro_2000_0698
crossref_primary_10_1023_A_1011950415325
crossref_primary_10_1016_S1286_4579_99_80009_4
crossref_primary_10_1128_JVI_76_1_251_258_2002
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1089/vim.1996.9.65
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
ExternalDocumentID 8822623
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
.GJ
0R~
1-M
123
29Q
34G
39C
3V.
4.4
53G
5RE
6AZ
7X7
88E
8C1
8FE
8FH
8FI
8FJ
AAHBH
ABBKN
ABJNI
ABUWG
ACGFS
ACPRK
ADBBV
AENEX
AFKRA
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
BBNVY
BENPR
BHPHI
BNQNF
BPHCQ
BVXVI
CAG
CCPQU
CGR
COF
CS3
CUY
CVF
DU5
EBS
ECM
EIF
EJD
F5P
FYUFA
HCIFZ
HMCUK
IAO
IHR
IM4
ITC
LK8
M1P
M7P
MV1
NPM
NQHIM
O9-
P2P
PQQKQ
PROAC
PSQYO
RIG
RML
RMSOB
UE5
UKHRP
7X8
SCNPE
ID FETCH-LOGICAL-c398t-638a22d93b45abd41fc3a5ca2fd4bca1ea14a257b35eb2c1f78d7c1caac4d15d2
IEDL.DBID 7X8
ISICitedReferencesCount 27
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=10.1089_vim.1996.9.65&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0882-8245
IngestDate Thu Sep 04 17:24:00 EDT 2025
Sat Sep 28 07:35:44 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c398t-638a22d93b45abd41fc3a5ca2fd4bca1ea14a257b35eb2c1f78d7c1caac4d15d2
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 8822623
PQID 78365224
PQPubID 23479
ParticipantIDs proquest_miscellaneous_78365224
pubmed_primary_8822623
PublicationCentury 1900
PublicationDate 1996-01-01
PublicationDateYYYYMMDD 1996-01-01
PublicationDate_xml – month: 01
  year: 1996
  text: 1996-01-01
  day: 01
PublicationDecade 1990
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Viral immunology
PublicationTitleAlternate Viral Immunol
PublicationYear 1996
SSID ssj0008683
Score 1.5334313
Snippet The measles virus (MV) nucleocapsid (N) protein gene has been inserted into a plasmid vector so as to place the gene under the control of the strong...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 65
SubjectTerms Animals
Antibodies, Viral - blood
Cell Line
DNA, Viral - immunology
Gene Expression
Humans
Immunization
Immunoglobulin G - blood
Measles - prevention & control
Measles Vaccine
Measles virus - genetics
Mice
Mice, Inbred C3H
Nucleoproteins - genetics
Plasmids - genetics
Vaccines, DNA
Viral Proteins - genetics
Title Immunization of mice with plasmid DNA expressing the measles virus nucleoprotein gene
URI https://www.ncbi.nlm.nih.gov/pubmed/8822623
https://www.proquest.com/docview/78365224
Volume 9
WOSCitedRecordID wos10.1089_vim.1996.9.65&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3LS8MwGA_TiXjxPZzPHLxmrmnSNiDIUIeCKzs42a2kSSoF1851G_75fukDT-LBS28p4Xv11-_x-xC6DjRT2uEBMQEXhLGkT4QnYuIJwwVVzPByS8Tbix-GwXQqxi1028zC2LbKJiaWgVrnyubIb-y0AWAFdjf_JHZnlK2t1gs0NlDbBSBjG7r86Q9XeOBVJJwWQwaU8Zphsx-Im3U6s2N6Xk_0PP47tiy_McO9_91uH-3W2BIPKmM4QC2THaLtUV09P0KT53IYpBq8xHmC7Sp6bDOxeA4gepZq_BAOsPmqmmOzdwzoEM-MLD5MgdfpYlXgzPIf5yW7Q5phsD5zjCbDx9f7J1KvVSAKhLQk4HGSUi3cmHEZa-YkypVcSZpoFivpGOkwCZ4cuxx-u5WT-IH2laOkVAzUqmkHbWZ5Zk4QZokf911Qd6I9OEvhddzRELMMFcyRpouuGnFFYLa2FiEzk6-KqBFYF3UqiUfzil0jAnVRwGSnfx49QztVC7XNh5yjdgL-ai7Qllov02JxWRoDPMPx6BvsfMFy
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Immunization+of+mice+with+plasmid+DNA+expressing+the+measles+virus+nucleoprotein+gene&rft.jtitle=Viral+immunology&rft.au=Fooks%2C+A+R&rft.au=Jeevarajah%2C+D&rft.au=Warnes%2C+A&rft.au=Wilkinson%2C+G+W&rft.date=1996-01-01&rft.issn=0882-8245&rft.volume=9&rft.issue=2&rft.spage=65&rft_id=info:doi/10.1089%2Fvim.1996.9.65&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0882-8245&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0882-8245&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0882-8245&client=summon